| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 0 | 44.128 | 49.514 | 65.801 | 77.454 |
| Total Income - EUR | - | - | - | - | - | 0 | 46.175 | 51.948 | 65.801 | 77.454 |
| Total Expenses - EUR | - | - | - | - | - | 1.355 | 15.339 | 24.612 | 32.711 | 35.710 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -1.355 | 30.836 | 27.335 | 33.090 | 41.744 |
| Net Profit/Loss - EUR | - | - | - | - | - | -1.355 | 30.082 | 26.187 | 32.597 | 39.599 |
| Employees | - | - | - | - | - | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Moraru Medica S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 28 | 0 | 26.473 | 19.630 | 48.860 |
| Current Assets | - | - | - | - | - | 209 | 29.839 | 32.407 | 30.561 | 50.980 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 18 | 54 |
| Receivables | - | - | - | - | - | 0 | 3.276 | 24.763 | 24.803 | 40.878 |
| Cash | - | - | - | - | - | 209 | 26.563 | 7.644 | 5.740 | 10.048 |
| Shareholders Funds | - | - | - | - | - | -1.313 | 28.839 | 26.268 | 34.097 | 39.679 |
| Social Capital | - | - | - | - | - | 41 | 81 | 81 | 81 | 80 |
| Debts | - | - | - | - | - | 1.551 | 1.000 | 32.613 | 16.094 | 60.161 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Moraru Medica S.r.l.